Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 GBX | +7.14% | -3.23% | -68.09% |
May. 20 | IQ-AI subsidiary gets second FDA rare paediatric disease designation | AN |
May. 20 | IQ-AI's Imaging Biometrics Gets Second Rare Disease Designation for Drug Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-68.09% | 3.94M | |
-22.04% | 8.54B | |
+68.22% | 4.32B | |
-0.82% | 2.53B | |
-38.23% | 2.48B | |
-7.85% | 1.9B | |
-17.57% | 1.59B | |
-39.48% | 1.23B | |
+9.68% | 1.13B | |
+16.15% | 994M |
- Stock Market
- Equities
- IQAI Stock
- News IQ-AI Limited
- IQ-AI Subsidiary’s Glioblastoma Therapy Obtains Fast-Track Designation From US FDA